Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Eyes direct distribution to about one million outlets in the next few years

Zydus Wellness says open to bolt-on acquisitions and ramping up direct distribution

Stocks in news: Adani Wilmar, Nazara Technologies, Cipla, Zydus Wellness, Canara Bank and more

Stocks in news: Adani Wilmar, Nazara Technologies, Cipla and more

Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated May 17, 2022.

Buy Zydus Wellness: target of Rs 2250: Sharekhan

Zydus Wellness Q4 Review - Weakness Persists On Both Growth, Margin Fronts: Yes Securities

Zydus Wellness Consolidated March 2022 Net Sales at Rs 639.78 crore, up 5.62% Y-o-Y

Buzzing stocks: Bharti Airtel, DLF, L&T Infotech, Goldstone Tech, Equitas Holdings, Abbott India, Zydus Wellness, Quest Capital, KEC International, Panache Innovations, GMR Infra, Dr Lal Path Labs, SPARC, Jubilant Ingreiva, PI Industries, Interglobe Aviation

stocks that will see action today may 17

Broker’s Call: Zydus Wellness (Buy)

ICICI Securities is bullish on Zydus Wellness recommended buy rating on the stock with a target price of Rs 2250 in its research report dated April 02, 2022.

Buy Zydus Wellness: target of Rs 2250: ICICI Securities

After this acquisition, the company will become market leader with around 45% market share in the niche category, replacing Zydus Wellness’ Nycil. Emami’s own Navratna Cool Talc is No. 2 brand in this category.

Ample room for growth in first 5 years, Emami says on ‘Dermicool’ | The Financial Express

Sharekhan is bullish on Zydus Wellness has recommended buy on the stock with a revised price target (PT) of Rs. 2,505 in its research report dated February 02, 2022.

Buy Zydus Wellness; Target Of Rs 2,505: Sharekhan

ICICI Direct is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2200 in its research report dated February 03, 2021.

Buy Zydus Wellness; Target Of Rs 2200: ICICI Direct

Zydus Wellness Limited is an integrated consumer company, engaged in the development, production, marketing and distribution of health and wellness products.

Zydus Wellness Ltd

Zydus Wellness Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Zydus Wellness says open to bolt-on acquisitions and ramping up direct distribution

Stocks in news: Adani Wilmar, Nazara Technologies, Cipla and more

Buy Zydus Wellness: target of Rs 2250: Sharekhan

Zydus Wellness Q4 Review - Weakness Persists On Both Growth, Margin Fronts: Yes Securities

Zydus Wellness Consolidated March 2022 Net Sales at Rs 639.78 crore, up 5.62% Y-o-Y

stocks that will see action today may 17

Broker’s Call: Zydus Wellness (Buy)

Zydus Wellness Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Zydus Wellness says open to bolt-on acquisitions and ramping up direct distribution

Stocks in news: Adani Wilmar, Nazara Technologies, Cipla and more

Buy Zydus Wellness: target of Rs 2250: Sharekhan

Zydus Wellness Q4 Review - Weakness Persists On Both Growth, Margin Fronts: Yes Securities

Zydus Wellness Consolidated March 2022 Net Sales at Rs 639.78 crore, up 5.62% Y-o-Y

stocks that will see action today may 17

Broker’s Call: Zydus Wellness (Buy)

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock